USPTO serial 88051066
OLIZAYR
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BROOKSHIRE, DAVID AARON
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with OLIZAYR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
La Chaux-De-Fonds, CH
La Chaux-De-Fonds, CH
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maxim A. Voltchenko
MAXIM A. VOLTCHENKO KAPLAN BREYER SCHWARZ, LLP90 Matawan Road - Suite 201MATAWAN, NJ 07747UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the prevention and treatment of Chronic Idiopathic Urticaria; Pharmaceutical preparations and substances for treatment and/or alleviation of Rhinitis; Pharmaceutical preparations and substances for treatment and/or alleviation of Asthma; Pharmaceutical preparations and substances for treatment and/or alleviation of respiratory ailments and Chronic Obstructive Pulmonary Disease; Inhalers filled with pharmaceutical preparations for the treatment and alleviation of respiratory ailments and Chronic Obstructive Pulmonary Disease; Pharmaceutical preparations and substances for treatment and/or alleviation of IGE-mediated disorders; Pharmaceutical preparations and substances for treatment and/or alleviation of Atopic Dermatitis; Pharmaceutical preparations and substances for treatment and/or alleviation of Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis and other musculoskeletal disorders; Pharmaceutical preparations and substances for treatment and/or alleviation of Systemic Lupus Erythematosus | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 10, 2020 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 10, 2020 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 5, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 3, 2019 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 3, 2019 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 3, 2019 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 3, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 8, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 13, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 13, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 24, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 30, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 29, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 30, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 27, 2018 | NWAP | NEW APPLICATION ENTERED | — |